Diagnosis of covert hepatic encephalopathy without specialized tests

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 8, 2014, Pages

  Nabi, Eiman ^a   Thacker, Leroy R ^a   Wade, James B ^a   Sterling, Richard K ^a   Stravitz, R Todd ^a   Fuchs, Michael ^a   Heuman, Douglas M ^a   Bouneva, Iliana ^a   Sanyal, Arun J ^a   Siddiqui, Mohammad S ^a   Luketic, Velimir ^a   White, Melanie B ^a   Monteith, Pamela ^a   Noble, Nicole A ^a   Unser, Ariel ^a   Bajaj, Jasmohan S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; Cognition; HRQOL; Minimal hepatic encephalopathy; Psychometric tests; Sickness impact profile

Indexed keywords

ADULT; ALCOHOL LIVER CIRRHOSIS; AREA UNDER THE CURVE; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; COVERT HEPATIC ENCEPHALOPATHY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; NEUROLOGIC EXAMINATION; OUTPATIENT DEPARTMENT; QUALITY OF LIFE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SICKNESS IMPACT PROFILE; UNIVERSITY HOSPITAL; VALIDATION PROCESS; AGED; CLINICAL MEDICINE; COMPLICATION; EVALUATION STUDY; MIDDLE AGED; PROCEDURES; QUESTIONNAIRE; ALCOHOLISM; EXPERIMENTAL COGNITIVE TEST; NONALCOHOLIC FATTY LIVER; PROSPECTIVE STUDY;

ADULT; AGED; CLINICAL MEDICINE; DEMOGRAPHY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY;

EID: 84904397994     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.12.020     Document Type: Article

References (24)

1. Kappus M.R., Bajaj J.S. Covert hepatic encephalopathy: not as minimal as you might think. Clin Gastroenterol Hepatol 2012, 10:1208-1219.
2. Ortiz M., Jacas C., Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. JHepatol 2005, 42(Suppl):S45-S53.
3. Bajaj J.S., Etemadian A., Hafeezullah M., et al. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology 2007, 45:833-834.
4. Prasad S., Dhiman R.K., Duseja A., et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007, 45:549-559.
5. Kanwal F., Gralnek I.M., Hays R.D., et al. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol 2009, 7:793-799.
6. Younossi Z.M., Guyatt G., Kiwi M., et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999, 45:295-300.
7. Bergner M., Bobbitt R.A., Carter W.B., et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981, 19:787-805.
8. Groeneweg M., Moerland W., Quero J.C., et al. Screening of subclinical hepatic encephalopathy. JHepatol 2000, 32:748-753.
9. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
10. Bajaj J.S., Thacker L.R., Heuman D.M., et al. The Stroop smartphone application is a short and valid method to screen forminimal hepatic encephalopathy. Hepatology 2013, 58:1122-1132.
11. Bajaj J.S., Cordoba J., Mullen K.D., et al. Review article: the design of clinical trials in hepatic encephalopathy-an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 2011, 33:739-747.
12. Sidhu S.S., Goyal O., Mishra B.P., et al. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 2011, 106:307-316.
13. Bajaj J.S., Heuman D.M., Wade J.B., et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 2011, 140:478-487 e471.
14. Soriano G., Roman E., Cordoba J., et al. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology 2012, 55:1922-1930.
15. Weissenborn K., Ennen J.C., Schomerus H., et al. Neuropsychological characterization of hepatic encephalopathy. JHepatol 2001, 34:768-773.
16. Bajaj J.S., Hafeezullah M., Zadvornova Y., et al. The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am J Gastroenterol 2009, 104:898-905.
17. Bajaj J.S., Thacker L.R., Wade J.B., et al. PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment Pharmacol Ther 2011, 34:1123-1132.
18. Amodio P., Bemeur C., Butterworth R., et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology 2013, 58:325-336.
19. Lauridsen M.M., Gronbaek H., Naeser E.B., et al. Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis 2012, 27:559-565.
20. Montagnese S., Biancardi A., Schiff S., et al. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology 2011, 53:558-566.
21. Nardelli S., Pentassuglio I., Pasquale C., et al. Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients. Metab Brain Dis 2013, 28:239-243.
22. Schomerus H., Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001, 16:37-41.
23. Mellinger J.L., Volk M.L. Multidisciplinary management of patients with cirrhosis: a need for care coordination. Clin Gastroenterol Hepatol 2012, 11:217-223.
24. Wunsch E., Szymanik B., Post M., et al. Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study. Liver Int 2011, 31:980-984.